|D015428||Myocardial Reperfusion Injury NIH||1.00|
|D015427||Reperfusion Injury NIH||1.00|
|D014947||Wounds and Injuries NIH||0.18|
There is one clinical trial.
This is a prospective comparative cohort trial taking place during the first year of the Coronavirus-19 (COVID-19) pandemic in Spain. Chiropractic patients throughout Spain were invited to participate independently of the care received, including patients who had stopped visiting their chiropractors since the pandemic hit. The main exposure variable is the access to chiropractic care services, and the degree of this exposure during the months following initial lockdown phase in Spain. Participants will fill an online questionnaire with self-reported outcome-measures.
Description: Numerical Rating Scale (0-10, 0=no pain, 10=maximum pain)Measure: Pain intensity Time: 6 months
Description: Duration of pain symptoms, PREVIOUS to the study, measured in months (up to 3 months, more than 3 months)Measure: Pain duration Time: 6 months
Description: Ranges: Constant, every day, every week, occasionallyMeasure: Pain frequency Time: 6 months
Description: Categories: New pain, worsened, no change, improv, goneMeasure: Pain perceived improvement Time: 6 months
Description: From the Brief Pain Inventory (7 items, 0-10: 0= minimal score, 70=maximal score)Measure: Pain interference Time: 6 months
Description: Validated questionnaire (short version 4 items, 1-4: 4= minimal score, 16=maximal score)Measure: Pain Catastrophizing Scale Time: 6 months
Description: Validated questionnaire (short version 11 items, 0-3: 0=minimal score, 33=maximal score)Measure: Tampa Scale Kinesiophobia Time: 6 months
Description: Validated questionnaire (7 items , 1-3: 1= minimal score, 21=maximal score)Measure: General Anxiety Disorder scale Time: 6 months
Description: Questionnaire (12 items, 1-4: 1=minimal score, 48=maximal score)Measure: Fear of Illness and Virus Evaluation Time: 6 months
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports